Results 201 to 210 of about 12,080 (218)

Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Elizabeth A Mittendorf, Hope S Rugo, Gabriel N Hortobagyi   +2 more
exaly  

Targeting receptor complexes: a new dimension in drug discovery

Nature Reviews Drug Discovery, 2020
Mette Ishøy Rosenbaum, Louise Albertsen, David S Bredt   +2 more
exaly  

Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes

Nature Reviews Drug Discovery, 2011
Uwe Rudolph
exaly  

Histamine H3- Receptor Agonists and Antagonists

2008
Holger Stark, Walter Schunack
openaire   +1 more source

Development of subtype-selective oestrogen receptor-based therapeutics

Nature Reviews Drug Discovery, 2011
Jan-Ake Gustafsson
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Targeting pathological B cell receptor signalling in lymphoid malignancies

Nature Reviews Drug Discovery, 2013
Ryan M Young, Louis M Staudt
exaly  

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

Nature Reviews Drug Discovery, 2012
P Mark Hogarth
exaly  

Histamine H3 receptor (HRH3); norepinephrine transporter

Science-Business eXchange, 2010
openaire   +1 more source

Amine-constrained pyridazinone histamine H3 receptor antagonists

Bioorganic & Medicinal Chemistry Letters, 2011
Babu G. Sundar, Thomas Bailey, Edward Bacon, Lisa Aimone, Zeqi Huang, Jacquelyn Lyons, Rita Raddatz, Robert Hudkins   +7 more
openaire   +1 more source